Zn Inhibits Coronavirus and Arterivirus RNA Polymerase Activity and Zinc Ionophores Block the Replication of These Viruses in Cell Culture

English version České info

Increasing the intracellular Zn²⁺ concentration with zinc-ionophores like pyrithione (PT) can efficiently impair the replication of a variety of RNA viruses, including poliovirus and influenza virus. For some viruses this effect has been attributed to interference with viral polyprotein processing. In this study we demonstrate that the combination of Zn²⁺ and PT at low concentrations (2 µM Zn²⁺ and 2 µM PT) inhibits the replication of SARS-coronavirus (SARS-CoV) and equine arteritis virus (EAV) in cell culture. The RNA synthesis of these two distantly related nidoviruses is catalyzed by an RNA-dependent RNA polymerase (RdRp), which is the core enzyme of their multiprotein replication and transcription complex (RTC). Using an activity assay for RTCs isolated from cells infected with SARS-CoV or EAV—thus eliminating the need for PT to transport Zn²⁺ across the plasma membrane—we show that Zn²⁺ efficiently inhibits the RNA-synthesizing activity of the RTCs of both viruses. Enzymatic studies using recombinant RdRps (SARS-CoV nsp12 and EAV nsp9) purified from E. coli subsequently revealed that Zn²⁺ directly inhibited the in vitro activity of both nidovirus polymerases. More specifically, Zn²⁺ was found to block the initiation step of EAV RNA synthesis, whereas in the case of the SARS-CoV RdRp elongation was inhibited and template binding reduced. By chelating Zn²⁺ with MgEDTA, the inhibitory effect of the divalent cation could be reversed, which provides a novel experimental tool for in vitro studies of the molecular details of nidovirus replication and transcription.

Vyšlo v časopise: Zn Inhibits Coronavirus and Arterivirus RNA Polymerase Activity and Zinc Ionophores Block the Replication of These Viruses in Cell Culture. PLoS Pathog 6(11): e32767. doi:10.1371/journal.ppat.1001176
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001176

Souhrn

Zdroje

1. LazarczykM

FavreM

2008 Role of Zn2+ ions in host-virus interactions. J Virol 82 11486 11494

2. FredericksonCJ

KohJY

BushAI

2005 Neurobiology of zinc in health and disease. Nat Rev Neurosci 6 449 462

3. AlirezaeiM

NairnAC

GlowinskiJ

PremontJ

MarinP

1999 Zinc inhibits protein synthesis in neurons: potential rol of phosphorylation of translation initiation factor-2a. J Biol Chem 274 32433 32438

4. UchideN

OhyamaK

BesshoT

YuanB

YamakawaT

2002 Effect of antioxidants on apoptosis induced by influenza virus infection: inhibition of viral gene replication and transcription with pyrrolidine dithiocarbamate. Antiviral Res 56 207 217

5. SuaraRO

CroweJEJ

2004 Effect of zinc salts on respiratory syncytial virus replication. Antimicrob Agents Chemother 48 783 790

6. GaudernakE

SeipeltJ

TriendlA

GrassauerA

KuechlerE

2002 Antiviral Effects of Pyrrolidine Dithiocarbamate on Human Rhinoviruses. J Virol 76 6004 6015

7. SiX

McManusBM

ZhangJ

YuanJ

CheungC

2005 Pyrrolidine Dithiocarbamate Reduces Coxsackievirus B3 Replication through Inhibition of the Ubiquitin-Proteasome Pathway. J Virol 79 8014 8023

8. KorantBD

KauerJC

ButterworthBE

1974 Zinc ions inhibit replication of rhinoviruses. Nature 248 588 590

9. PolatnickJ

BachrachHL

1978 Effect of zinc and other chemical agents on foot-and-mouth-disease virus replication. Antimicrob Agents Chemother 13 731 734

10. LankeK

KrennBM

MelchersWJG

SeipeltJ

van KuppeveldFJM

2007 PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells. J Gen Virol 88 1206 1217

11. KrennBM

GaudernakE

HolzerB

LankeK

Van KuppeveldFJM

2009 Antiviral Activity of the Zinc Ionophores Pyrithione and Hinokitiol against Picornavirus Infections. J Virol 83 58 64

12. ZalewskiPD

ForbesIJ

BettsWH

1993 Correlation of apoptosis with change in intracellular labile Zn(II) using Zinquin [(2-methyl-8-p-toluenesulphonamide-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J 296 403 408

13. BaumEZ

BebernitzGA

PalantO

MuellerT

PlotchSJ

1991 Purification, properties, and mutagenesis of poliovirus 3C protease. Virology 165 140 150

14. CordingleyMG

RegisterRB

CallahanPL

GarskyVM

ColonnoRJ

1989 Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. J Virol 63 5037 5045

15. FerrariE

Wright-MinogueJ

FangJW

BaroudyBM

LauJY

1999 Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol 73 1649 1654

16. HungM

GibbsCS

TsiangM

2002 Biochemical characterization of rhinovirus RNA-dependent RNA polymerase. Antiviral Res 56 99 114

17. PerlmanS

NetlandJ

2009 Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Micro 7 439 450

18. GorbalenyaAE

EnjuanesL

ZiebuhrJ

SnijderEJ

2006 Nidovirales: evolving the largest RNA virus genome. Virus Res 117 17 37

19. SnijderEJ

BredenbeekPJ

DobbeJC

ThielV

ZiebuhrJ

2003 Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331 991 1004

20. PasternakAO

SpaanWJ

SnijderEJ

2006 Nidovirus transcription: how to make sense…? J Gen Virol 80 1403 1421

21. SawickiSG

SawickiDL

SiddellSG

2007 A Contemporary View of Coronavirus Transcription. J Virol 81 20 29

22. ButterworthBE

KorantBD

1974 Characterization of the large picornaviral polypeptides produced in the presence of zinc ion. J Virol 14 282 291

23. DenisonMR

PerlmanS

1986 Translation and processing of mouse hepatitis virus virion RNA in a cell-free system. J Virol 60 12 18

24. DenisonMR

ZoltickPW

HughesSA

GiangrecoB

OlsonAL

1992 Intracellular processing of the N-terminal ORF 1a proteins of the coronavirus MHV-A59 requires multiple proteolytic events. Virology 189 274 284

25. van HemertMJ

de WildeAH

GorbalenyaAE

SnijderEJ

2008 The in Vitro RNA Synthesizing Activity of the Isolated Arterivirus Replication/Transcription Complex Is Dependent on a Host Factor. J Biol Chem 283 16525 16536

26. van HemertMJ

van den WormSHE

KnoopsK

MommaasAM

GorbalenyaAE

2008 SARS-Coronavirus Replication/Transcription Complexes Are Membrane-Protected and Need a Host Factor for Activity In Vitro. PLoS Pathog 4 e1000054

27. te VelthuisAJ

ArnoldJJ

CameronCE

van den WormSH

SnijderEJ

2009 The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent. Nucleic Acids Res 38 203 214

28. BeerensN

SeliskoB

RicagnoS

ImbertI

van der ZandenL

2007 De Novo Initiation of RNA Synthesis by the Arterivirus RNA-Dependent RNA Polymerase. J Virol 81 8384 8395

29. van den BornE

PosthumaCC

KnoopsK

SnijderEJ

2007 An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene. J Gen Virol 88 1196 1205

30. SimsAC

BurkettSE

YountB

PicklesRJ

2008 SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium. Virus Res 133 33 44

31. XuX

LiuY

WeissS

ArnoldE

SarafianosSG

2003 Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res 31 7117 7130

32. ZhaiY

SunF

LiX

PangH

XuX

2005 Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer. Nat Struct Mol Biol 12 980 986

33. StockmanLJ

BellamyR

GarnerP

2006 SARS: Systematic Review of Treatment Effects. PLoS Med 3 e343

34. ThompsonA

PatelK

TillmanH

McHutchisonJG

2009 Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges. J Hepatol 50 184 194

35. De ClercqE

2004 Antivirals and antiviral strategies. Nat Rev Microbiol 2 704 720

36. ThompsonAJV

McHutchisonJG

2009 Antiviral resistance and specifically targeted therapy for HCV (STAT-C). J Viral Hepat 16 377 387

37. YangW

LeeJY

NowotnyM

2006 Making and Breaking Nucleic Acids: Two-Mg2+-Ion Catalysis and Substrate Specificity. Mol Cell 22 5 13

38. CastroC

SmidanskyE

MaksimchukKR

ArnoldJJ

KorneevaVS

2007 Two proton transfers in the transition state for nucleotidyl transfer catalyzed by RNA- and DNA-dependent RNA and DNA polymerases. Proc Natl Acad Sci USA 104 4267 4272

39. ArnoldJJ

GhoshSK

CameronCE

1999 Poliovirus RNA-dependent RNA Polymerase (3Dpol). Divalent cation modulation of primer, template and nucleotide selection. J Biol Chem 274 37060 37069

40. IuchiS

2001 Three classes of C2H2 zinc finger proteins. Cell Mol Life Sci 58 625 635

41. Gomis-RuthXF

2009 Catalytic domain architecture of metzincin metalloproteases. J Biol Chem 284 15353 15357

42. YapTL

XuT

ChenY-L

MaletH

EgloffM-P

2007 Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution. J Virol 81 4753 4765

43. WinekCL

BuehlerEV

1966 Intravenous toxicity of zinc pyridinethione and several zinc salts. Toxicol Appl Pharmacol 9 296 273

44. SnyderDR

de JesusCP

TowfighiJ

JacobyRO

WedigJH

1979 Neurological, microscopic and enzyme-histochemical assessment of zinc pyrithione toxicity. Food Cosmet Toxicol 17 651 660

45. MagdaD

LecaneP

WangZ

HuW

ThiemannP

2008 Synthesis and anticancer properties of water-soluble zinc ionophores. Cancer Res 68 5318 5325

46. SnijderEJ

van der MeerY

Zevenhoven-DobbeJ

OnderwaterJJM

van der MeulenJ

2006 Ultrastructure and Origin of Membrane Vesicles Associated with the Severe Acute Respiratory Syndrome Coronavirus Replication Complex. J Virol 80 5927 5940

47. StudierF

2005 Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 41 207 234